NASDAQ

Henry Schein, Inc. (HSIC)

368 Thanks from members

Henry Schein, Inc. (HSIC) demonstrates robust Q2 2026 financial results, highlighted by strong sales of $3.5 billion, margin expansion, and a raised full-year guidance, driving positive analyst sentiment despite lingering macroeconomic and debt-related caution.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →